Am J Psychiatry 158:256-265, February 2001
© 2001 American Psychiatric Association
GABA Transporter-1 mRNA in the Prefrontal Cortex in Schizophrenia: Decreased Expression in a Subset of Neurons
David W. Volk, M.S.,
Mark C. Austin, Ph.D.,
Joseph N. Pierri, M.S., M.D.,
Allan R. Sampson, Ph.D., and
David A. Lewis, M.D.
OBJECTIVE: Within the prefrontal cortex of schizophrenic subjects, alterations in markers of  -aminobutyric acid (GABA) neurotransmission, including decreased immunoreactivity for the GABA membrane transporter GAT-1, may be most prominent in a subset of inhibitory neurons. In the present study, the authors sought to determine whether the alterations in GAT-1 protein could be attributed to a reduction in GAT-1 mRNA expression. METHOD: Tissue sections containing prefrontal cortex area 9 from 10 matched pairs of schizophrenic and comparison subjects were processed for in situ hybridization histochemistry with 35S-oligonucleotide probes for GAT-1 mRNA. RESULTS: In the schizophrenic subjects, the relative density of labeled neurons was 21%–33% lower in layers 1–5 of the prefrontal cortex but was unchanged in layer 6. In contrast, cellular levels of GAT-1 mRNA expression, as reflected in grain density per labeled neuron, did not differ by more than 11% between subject groups in any layer. These findings indicate that GAT-1 mRNA expression is relatively unaltered in the majority of prefrontal cortex GABA neurons in schizophrenic subjects but is reduced below a detectable level in a subset of GABA neurons. Furthermore, the magnitude and laminar pattern of these results were strikingly similar to those found in a previous study of mRNA expression for the synthesizing enzyme of GABA, glutamic acid decarboxylase67, in the same subjects. CONCLUSIONS: Both GABA synthesis and reuptake appear to be altered at the level of gene expression in a subset of GABA neurons, and the resulting changes in GABA neurotransmission may contribute to prefrontal cortex dysfunction in schizophrenia.
This article has been cited by other articles:
|
|
|
|
 
T. Hashimoto, H. H. Bazmi, K. Mirnics, Q. Wu, A. R. Sampson, and D. A. Lewis
Conserved Regional Patterns of GABA-Related Transcript Expression in the Neocortex of Subjects With Schizophrenia
Am J Psychiatry,
April 1, 2008;
165(4):
479 - 489.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. L. Lazar, N. Rajakumar, and D. P. Cain
Injections of NGF Into Neonatal Frontal Cortex Decrease Social Interaction as Adults: A Rat Model of Schizophrenia
Schizophr Bull,
January 1, 2008;
34(1):
127 - 136.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Menzies, C. Ooi, S. Kamath, J. Suckling, P. McKenna, P. Fletcher, E. Bullmore, and C. Stephenson
Effects of {gamma}-Aminobutyric Acid-Modulating Drugs on Working Memory and Brain Function in Patients With Schizophrenia
Arch Gen Psychiatry,
February 1, 2007;
64(2):
156 - 167.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Lewis and B. Moghaddam
Cognitive Dysfunction in Schizophrenia: Convergence of {gamma}-Aminobutyric Acid and Glutamate Alterations.
Arch Neurol,
October 1, 2006;
63(10):
1372 - 1376.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. O. Cunningham, J. Hunt, S. Middleton, F. E. N. LeBeau, M. G. Gillies, C. H. Davies, P. R. Maycox, M. A. Whittington, and C. Racca
Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness.
J. Neurosci.,
March 8, 2006;
26(10):
2767 - 2776.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Pillai-Nair, A. K. Panicker, R. M. Rodriguiz, K. L. Gilmore, G. P. Demyanenko, J. Z. Huang, W. C. Wetsel, and P. F. Maness
Neural Cell Adhesion Molecule-Secreting Transgenic Mice Display Abnormalities in GABAergic Interneurons and Alterations in Behavior
J. Neurosci.,
May 4, 2005;
25(18):
4659 - 4671.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. A. Petrie, D. Schmidt, M. Bubser, J. Fadel, R. E. Carraway, and A. Y. Deutch
Neurotensin Activates GABAergic Interneurons in the Prefrontal Cortex
J. Neurosci.,
February 16, 2005;
25(7):
1629 - 1636.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Veldic, A. Guidotti, E. Maloku, J. M. Davis, and E. Costa
In psychosis, cortical interneurons overexpress DNA-methyltransferase 1
PNAS,
February 8, 2005;
102(6):
2152 - 2157.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Hashimoto, S. E. Bergen, Q. L. Nguyen, B. Xu, L. M. Monteggia, J. N. Pierri, Z. Sun, A. R. Sampson, and D. A. Lewis
Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia
J. Neurosci.,
January 12, 2005;
25(2):
372 - 383.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T.-U. W. Woo, J. P. Walsh, and F. M. Benes
Density of Glutamic Acid Decarboxylase 67 Messenger RNA-Containing Neurons That Express the N-Methyl-D-Aspartate Receptor Subunit NR2A in the Anterior Cingulate Cortex in Schizophrenia and Bipolar Disorder
Arch Gen Psychiatry,
July 1, 2004;
61(7):
649 - 657.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. LEWIS, D. CRUZ, S. EGGAN, and S. ERICKSON
Postnatal Development of Prefrontal Inhibitory Circuits and the Pathophysiology of Cognitive Dysfunction in Schizophrenia
Ann. N.Y. Acad. Sci.,
June 1, 2004;
1021(1):
64 - 76.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. T. COYLE, G. TSAI, and D. GOFF
Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of Schizophrenia
Ann. N.Y. Acad. Sci.,
November 1, 2003;
1003(1):
318 - 327.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kromkamp, H. B. M. Uylings, M. P. Smidt, A. J. C. G. M. Hellemons, J. P. H. Burbach, and R. S. Kahn
Decreased Thalamic Expression of the Homeobox Gene DLX1 in Psychosis
Arch Gen Psychiatry,
September 1, 2003;
60(9):
869 - 874.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Hashimoto, D. W. Volk, S. M. Eggan, K. Mirnics, J. N. Pierri, Z. Sun, A. R. Sampson, and D. A. Lewis
Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia
J. Neurosci.,
July 16, 2003;
23(15):
6315 - 6326.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. A. Morrow, J. D. Elsworth, and R. H. Roth
Axo-Axonic Structures in the Medial Prefrontal Cortex of the Rat: Reduction by Prenatal Exposure to Cocaine
J. Neurosci.,
June 15, 2003;
23(12):
5227 - 5234.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. W. Volk, J. N. Pierri, J.-M. Fritschy, S. Auh, A. R. Sampson, and D. A. Lewis
Reciprocal Alterations in Pre- and Postsynaptic Inhibitory Markers at Chandelier Cell Inputs to Pyramidal Neurons in Schizophrenia
Cereb Cortex,
October 1, 2002;
12(10):
1063 - 1070.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B Dean
Understanding the pathology of schizophrenia: recent advances from the study of the molecular architecture of postmortem CNS tissue
Postgrad. Med. J.,
March 1, 2002;
78(917):
142 - 148.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Lewis, D. A. Cruz, D. S. Melchitzky, and J. N. Pierri
Lamina-Specific Deficits in Parvalbumin-Immunoreactive Varicosities in the Prefrontal Cortex of Subjects With Schizophrenia: Evidence for Fewer Projections From the Thalamus
Am J Psychiatry,
September 1, 2001;
158(9):
1411 - 1422.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2001
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
